Menu
Search for Stories

News Stories - Page 552

CAES News
Farm income outlook for 2005 not good, not too bad
Net farm income for Georgia farmers in 2005 probably won't be as good as in 2004. But it should be a little better than earlier this decade.
CAES News
Fanning lecture, awards luncheon Jan. 14 in Athens
USDA deputy chief economist Joseph Glauber will speak on "Agricultural Policy and the World Trade Organization" for the annual J.W. Fanning Lecture Jan. 14 in Athens, Ga.
CAES News
Cloned cow brings a little Sunshine into world
In a country clouded by a deep suspicion of foods from cloned animals, a little Sunshine may help soften consumers' fears. Sunshine is a female calf. The only thing special about her is her mama, the first cow ever cloned from cells collected from a beef carcass.
CAES News
2004 in review: Georgia FACES news highlights
Between the Christmas gifts and the New Year's resolutions, you may want to look back on the news of 2004 before you get started on 2005. Here's a look at the year's top stories.
CAES News
Save your poinsettia for use next Christmas
When the holidays are over and you pack away the decorations, don't pitch the poinsettia plant. If you're up for a challenge, this year's poinsettia could become a part of your holiday decorations next year.
CAES News
Tobacco settlement money may not get to farmers
Georgia tobacco farmers' share of money from a 1998 tobacco settlement that compensates states for smoking-related health problems will be late -- if it comes at all.
CAES News
Chinese grass germ plasm leads to new varieties
Turf scientists at the University of Georgia are breeding new varieties of centipede grass using germ plasm collected from the grass's homeland, China.
CAES News
Georgia cotton good -- quality needs to improve
Despite an arid midsummer and tropical storms in early fall, Georgia's 2004 cotton crop is surprisingly good. But the quality still needs improving for farmers to consistently sell their crop on the competitive world market.
CAES News
Scientists making stem-cell-based SMA drug test
Researchers at the University of Georgia have been awarded a $425,598 subcontract to develop a human embryonic stem-cell–derived test for screening drugs capable of treating spinal muscular atrophy, the No. 1 genetic killer of children under 2 years old.

About the Newswire

The CAES newswire features the latest popular science and lifestyle stories relating to agricultural, consumer and environmental sciences as well as UGA Extension programs and services around the state.

Media Contacts